Free Trial
NYSEARCA:PJP

Invesco Pharmaceuticals ETF (PJP) Price, Holdings, & News

$79.12
-0.21 (-0.26%)
(As of 05/24/2024 08:00 PM ET)
Today's Range
$79.12
$79.60
50-Day Range
$75.33
$81.20
52-Week Range
$67.75
$81.20
Volume
1,000 shs
Average Volume
21,625 shs
Market Capitalization
$268.22 million
Assets Under Management
$267.58 million
Dividend Yield
0.95%
Net Expense Ratio
0.57%

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund’s investment advisor is Invesco PowerShares Capital Management LLC.

PJP Stock Price History

PJP ETF News Headlines

See More Headlines
Receive PJP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Invesco
Fund Name
Invesco Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:PJP
Inception Date
6/23/2005
Fund Manager
Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser

Fund Focus

Asset Class
Equity
Benchmark
Dynamic Pharmaceutical Intellidex Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
27

Fund Statistics

Assets Under Management
$267.58 million
Average Daily Volume
$6,227.10
Discount/Premium
-0.05%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
N/A
Short Interest
5,700 shs

Miscellaneous

Beta
0.61
Creation Unit
10,000
Creation Fee
$500.00
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Invesco Pharmaceuticals ETF Expenses

TypePJPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.56%0.54%0.51%0.51%
Other Expenses0.07%0.40%0.54%0.64%0.58%
Total Expense0.57%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%
Net Expense0.57%0.60%0.60%0.58%0.58%

Invesco Pharmaceuticals ETF (PJP) Holdings & Exposure

PJP Sector Exposure

PJP Industry Exposure

Key Executives

  • H. Bruce Bond (Age 49)
    Chairman of the Board of Trustee, Chief Executive Officer
  • Bruce T. Duncan (Age 60)
    Chief Financial Officer, Treasurer
  • Kevin R. Gustafson (Age 43)
    Chief Compliance Officer
  • Keith A Ovitt (Age 50)
    Secretary
  • Ronn R. Bagge (Age 55)
    Trustee
  • Marc M Kole (Age 53)
    Trustee
  • D. Mark McMillan (Age 49)
    Trustee
  • Philip M. Nussbaum Mba (Age 52)
    Trustee
  • Donald H. Wilson (Age 55)
    Trustee

PJP ETF - Frequently Asked Questions

How have PJP shares performed in 2024?

Invesco Pharmaceuticals ETF's stock was trading at $76.10 at the beginning of the year. Since then, PJP stock has increased by 4.0% and is now trading at $79.12.
View the best growth stocks for 2024 here
.

What does PJP invest in?

Invesco Pharmaceuticals ETF is a equity fund issued by Invesco. PJP focuses on health care investments and follows the Dynamic Pharmaceutical Intellidex Index. The fund's investments total to approximately $267.58 million assets under management.

What stocks does Invesco Pharmaceuticals ETF hold?
What is the management fee for Invesco Pharmaceuticals ETF?

Invesco Pharmaceuticals ETF's management fee is 0.50% and has other expenses of 0.07%. The net expense ratio for PJP is 0.57%.

What other stocks do shareholders of Invesco Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Pharmaceuticals ETF investors own include iShares 20+ Year Treasury Bond ETF (TLT), Verizon Communications (VZ), iShares Russell 2000 ETF (IWM), Akcea Therapeutics (AKCA), BOX (BOX), Kraft Heinz (KHC), Morgan Stanley (MS), Netflix (NFLX) and Applied Materials (AMAT).

Who are Invesco Pharmaceuticals ETF's major shareholders?

Invesco Pharmaceuticals ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Peak Asset Management LLC (4.02%), Cambridge Investment Research Advisors Inc. (1.13%), Global Assets Advisory LLC (0.91%), Fortis Group Advisors LLC (0.75%), Commonwealth Equity Services LLC (0.65%) and Dumont & Blake Investment Advisors LLC (0.56%).

How do I buy shares of Invesco Pharmaceuticals ETF?

Shares of PJP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:PJP) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners